Mayo Clinic awarded federal grant to study experimental ALS drug

Getty Images JACKSONVILLE, Fla. — Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NINDS) to begin an innovative study that will provide hundreds of patients with amyotrophic lateral sclerosis (ALS) access to the experimental drug ibudilast over six months. The grant totals $22 million. Mayo Clinic will receive $12 million and manage the distribution of the remainder to its collaborators. The U.S. Food and Drug Administration…